Athelas
YC S16 ↗San Francisco, US · Founded 2016 · Delaware corporation · 1000 employees · 9 known investors
Athelas develops software tools for private practice healthcare providers to reduce administrative burden, improve operational efficiency, and enhance patient scheduling and navigation capabilities.
AI & Machine LearningEnterprise SoftwareHealthtechSaaSHealth TechTelehealthHealthcareAIin /athelas/@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (S16)
Investors · 9
Amity VenturesSan Francisco · $1M – $5M
Dorm RoomBrooklyn · $90K – $250K
Fifty YearsSan Francisco · $250K – $2M
General CatalystSan Francisco · $30M
Human CapitalSan Francisco · $250K – $200M
Liquid VenturesSan Francisco · $250K – $5M
Y CombinatorSan Francisco · $500K
Sequoia CapitalreportedMenlo Park · $4.4M – $214M
Shasta VenturesreportedMenlo Park · $250K – $6M
Reported raises · per SEC filings
Form D private placements▶$54.4MraisedFeb 2022 · 17 investors · OtherRule 506(b)
Officers, directors & promoters on the filing
- Hemant TanejaDirector
- Deepika BodapatiDirector
- Tanay TandonExecutive Officer, Director
- Offering amount
- $59.4M
- Amount sold
- $54.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Commure Athelas Highlights AI-Driven Efficiency and High-Valuation Funding - TipRanks.comtipranks.com · 2026
- Athelas Lands $70 Million at $7 Billion Valuation as AI-Driven RCM Traction Grows - TipRanks.comtipranks.com · 2026
- Commure raises $70M, boosting post-money valuation to $7B | MobiHealthNewsmobihealthnews.com · 2026
- Athelas + Commure: Merging to Create a $6B Healthcare Infrastructure Companyathelas.com · 2023
- Deepika Bodapati and Tanay Tandon of Athelas: The Listeners | Sequoia Capital US/Europesequoiacap.com · 2022
- RPM tech provider Athelas hits unicorn status with $132M raised for chronic care management | Fierce Healthcarefiercehealthcare.com · 2022
- Health Startup Athelas Hits $1.5 Billion Valuation After Pandemic Boombloomberg.com · 2022
- Athelas is an at-home blood testing device made for cancer patientstechcrunch.com · 2017
